医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Seoul Viosys’ Violeds Technology for Escalator Handrail Sterilization Solutions

2020年12月08日 AM09:00
このエントリーをはてなブックマークに追加


 

ANSAN, South Korea

Seoul Viosys (KOSDAQ: 092190), a leading compound semiconductor solution provider, announced that ‘Violeds’ technology has been applied to an escalator handrail sterilization solution that is being supplied to leading global escalator and elevator OEMs by EHC Global Inc. (“EHC”), a Canadian-based manufacturer of integrated solutions for the vertical transportation industry.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201207005332/en/

EHC Safety+ Handrail Sterilizer with Violeds technology of Seoul Viosys (Graphic: Business Wire)

EHC Safety+ Handrail Sterilizer with Violeds technology of Seoul Viosys (Graphic: Business Wire)

Violeds is a clean technology that provides robust disinfection on the surface of handrails using UV LED light. It is optimally designed to match the speed, area, and distance of the handrail to disinfect 99.9% of harmful viruses and bacteria in the areas exposed to the light.

EHC’s handrail sterilization solutions with Violeds technology have already been installed on escalators and moving walks around the world in a wide range of environments including airports, public transit systems, commercial buildings, shopping malls, department stores, healthcare facilities, sports venues, museums and government buildings. EHC recently supplied Violeds technology applied escalator handrails to Ted Stevens Anchorage International Airport in Alaska in the U.S. and James Armstrong Richardson International Airport in Winnipeg, Canada.

“In response to the growing demand for vertical transportation solutions incorporating clean, antibacterial and disinfection technologies, EHC has implemented the Violeds UVC disinfection module by Seoul Viosys, the leading UV LED company,” said Patrick Bothwell, Vice President of Sales, EHC Global. “Thousands of installations have already been completed and we anticipate continued demand in 2021 and beyond.”

An official from Seoul Viosys said, “As COVID-19 pandemic continues, interest in the prevention of multi-use facilities is greatly increasing. It is absolutely necessary to apply Violeds which has proven to disinfect 99.9% of new coronavirus, for elevators and escalators in public facilities such as airports, hospitals, shopping malls, sports stadiums, even in air conditioning systems.”

Violeds technology has been adopted for 2021 electronics models of such as refrigerators, drying machines, washing machines of the global top three brands and Violeds products are in mass production.

About Seoul Viosys

Seoul Viosys is a full-line solution provider for UV LED, VCSEL (Vertical Cavity Surface Emitting Laser), the next-generation light source for 3D sensor and laser, and a single-pixel RGB “Micro Clean Pixel” for displays. Established in 2002 as a subsidiary of Seoul Semiconductor, it captured No. 1 market share in the UV LED industry (LEDinside, 2019). Seoul Viosys has an extensive UV LED portfolio with all wavelengths ranging from 200nm to 1600nm, including ultraviolet rays (UV), visible rays, and infrared rays. The company holds more than 4,000 patents related to UV LED technology. Violeds, its flagship UV LED technology, provides a wide range of industries with optimal solutions for robust sterilization and disinfection (UV-C), skin regeneration (UV-B), water/air purification and effective cultivation for horticulture. In 2018, Seoul Viosys acquired RayCan, a leading optoelectronic specialist, to add advanced VCSEL technology, which supports smartphone facial recognition and autonomous driving, and has started mass production. In January 2020, it introduced a disruptive “Micro Clean Pixel” that has the potential to be a game-changer in the display market. To learn more, visit http://www.seoulviosys.com/en/.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201207005332/en/

CONTACT

Media Contacts:

Seoul Semiconductor Co., Ltd.

Jeonghee Kim

Tel: +82-70-4391-8311

Email: jeonghee.kim@seoulsemicon.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • サラダックス・バイオメディカル、サルバトーレ・J・サラモネ博士が権威ある C.E. Pippenger博士賞を受賞したと発表
  • Japan’s MHLW Approves PADCEV® (enfortumab vedotin) for Advanced Urothelial Cancer
  • VFMCRP announces approval for TAVNEOS® (avacopan) for the treatment of ANCA-associated vasculitis in Japan
  • TAE Life Sciences Announces Installation of First Accelerator-based Neutron Beam System for Biologically Targeted Radiation Therapy at Xiamen Humanity Hospital in China
  • New Study Evaluates the Feasibility of Using Masimo EMMA® Capnography on Mechanically Ventilated Neonates